empty
 
 
pl
Wyszukaj
Obsługa klienta
Szybkie założenie konta
Platforma handlowa
Wpłata/Wypłata
Wyszukaj
Dla Początkujących Dla Traderów Dla Partnerów Zrób sobie przerwę Informacje o InstaSpot
pl
#DVAX Return to the list of instruments #ELAN

Currency converter

DexCom Inc.
60.76 USD
24 Apr 2026 21:59
Price Change (% chg)
$0.03
(0.05%)
Prev Close
Prev Close

Closing price, the previous day.
$61.77
Open
Open

Opening price.
$62.27
Day's High
Day's High

The highest price over the last trading day.
$62.26
Day's Low
Day's Low

The lowest price over the last trading day
$59.62
Week High
Week High

Price range high in the last week
$63.11
Week Low
Week Low

Price range low in the last week
$59.62
Download archive
Buy
60.76
Sell
60.76
Open the chart in full screen view
Buy
60.76
Sell
60.76
Download archive
Open the chart in full screen view

About DexCom Inc.

DexCom Inc. is a US-based medtech company established in 1999. The company is focused on developing and producing medical equipment. 

Its major product is a continuous glucose monitoring (CGM) system for people suffering from diabetes. The CGM system enables real-time continuous blood monitoring which is then transferred to a user's smart device.;

DexCom Inc. sells its products directly or through distributors in the United States and internationally. 

The company's market capitalization is currently estimated at $39.79 billion. Over the past year, it posted revenue of $2.448 billion and a net profit of $154.7 million. 

DexCom Inc. shares and what affects their value;

The shares of DexCom Inc. have been trading on the NASDAQ stock exchange under the ticker “DXCM” since 2005. The initial price of one share was $12.

At the moment, the stock is trading in the range between $99 and $103. Over the past year, the stock price fluctuated between a low of $66 and a high of $165.

What to consider when trading the asset:

  • The company has a good reputation and a brand that is recognized across the world;
  • Strong international presence;
  • The company develops its own mobile apps and prioritizes innovative technologies;
  • DexCom Inc. had no competitors for quite a long time. Today, however, other medical companies have presented a similar device and may easily claim its share in the market;
  • Strong competition forces the company to cut production costs and fight for customers’ attention by constantly improving its products;
  • The ability to collect data from patients using the company’s devices enables DexCom Inc. to develop personalized treatment plans.

Nie możesz teraz rozmawiać przez telefon?
Zadaj pytanie na czacie.